Source: Hepatology. Conference titles: Annual Meeting and Postgraduate Courses the American Association for the Study of Liver Diseases. Unidade: FM
Subjects: HEPATITE CRÔNICA, FARMACOTERAPIA, HEPATITE C
ABNT
GONCALES JUNIOR, Fernando L. et al. Peginterferon alpha-2B (peg-ifn)plus ribavirn (RBV) in Brazilian patients with chronic hepatitis C: 12 week viral clearence. Hepatology. Orlando: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 09 nov. 2024. , 2002APA
Goncales Junior, F. L., Vigani, A., Goncales, N., Coelho, H. S., Paixao, J., Rosa, H., et al. (2002). Peginterferon alpha-2B (peg-ifn)plus ribavirn (RBV) in Brazilian patients with chronic hepatitis C: 12 week viral clearence. Hepatology. Orlando: Faculdade de Medicina, Universidade de São Paulo.NLM
Goncales Junior FL, Vigani A, Goncales N, Coelho HS, Paixao J, Rosa H, Borges A, Barone AA, Araujo E, Focaccia R, Oliveira U, Ferraz ML, Perez R, Lobato C, Weirich J, Vila R, Giannella ML. Peginterferon alpha-2B (peg-ifn)plus ribavirn (RBV) in Brazilian patients with chronic hepatitis C: 12 week viral clearence. Hepatology. 2002 ; 36( 4): 588A.[citado 2024 nov. 09 ]Vancouver
Goncales Junior FL, Vigani A, Goncales N, Coelho HS, Paixao J, Rosa H, Borges A, Barone AA, Araujo E, Focaccia R, Oliveira U, Ferraz ML, Perez R, Lobato C, Weirich J, Vila R, Giannella ML. Peginterferon alpha-2B (peg-ifn)plus ribavirn (RBV) in Brazilian patients with chronic hepatitis C: 12 week viral clearence. Hepatology. 2002 ; 36( 4): 588A.[citado 2024 nov. 09 ]